Article Text

PDF
Whole anterior segment proton beam radiotherapy for diffuse iris melanoma
  1. Lazaros Konstantinidis1,
  2. Dawn Roberts2,
  3. R Douglas Errington3,
  4. Andrzej Kacperek3,
  5. Bertil Damato1,2
  1. 1Ocular Oncology Service, Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK
  2. 2Liverpool Ocular Oncology Research Group, Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
  3. 3Department of Oncology, Douglas Cyclotron, Clatterbridge Cancer Centre, Wirral, UK
  1. Correspondence to Professor Bertil Damato, St. Paul's Eye Unit, Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, L7 8XP, UK; Bertil{at}damato.co.uk

Abstract

Aim To report the results of whole anterior segment proton beam radiotherapy (PBR) for diffuse iris melanoma.

Methods Between 2000 and 2011, 12 patients with iris melanoma received PBR to the entire iris and ciliary body.

Results Patients had a mean age of 57 years and a median follow-up of 3.5 years (range 1–11.6 years). Tumour iris involvement was 1–4 h in five patients, 5–8 h in four and 9–12 h in three. Angle involvement was 6–8 h in five patients and 9–12 h in seven. The visual acuity (VA) before treatment was 6/5–6/6 in six patients, 6/8–6/9 in three and 6/18–6/38 in three. No tumour recurrence occurred during the follow-up period. Glaucoma treatment was required in 11 of 12 patients. The visual acuity at the last follow-up was 6/5–6/9 in five patients, 6/18–6/24 in three, 6/60–1/60 in two and no light perception in two. Four patients developed varying non-severe degrees of limbal stem cell deficiency, which was treatable with conservative measures.

Conclusions Whole anterior segment PBR is a useful alternative to enucleation for diffuse iris melanoma. Most patients will need treatment for glaucoma and some may require treatment for tear-film instability and/or stem cell failure.

  • Iris
  • Neoplasia

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.